(2) In terms of inflammatory regulation, DOPs reduce the inflammatory response in colon cancer mice (decreased TNF-α and IL-1β levels), restore the barrier function of the intestinal epithelium (increased ZO-1 and occludin expression), improve the tumor microenvironment, and inhibit tumor growth [86]. Here, IL1B is linked to neoplasm.